Search
Atinvicitinib
go.drugbank.com/drugs/DB21558ExperimentalAtinvicitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Atinvicitinib is a Janus kinase inhibitor. … Atinvicitinib has a monoisotopic molecular weight of 360.13 Da.
Fulimetibant
go.drugbank.com/drugs/DB21599ExperimentalFulimetibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Fulimetibant is a bradykinin receptor antagonist. … Fulimetibant has a monoisotopic molecular weight of 487.15 Da.
Adrixetinib
go.drugbank.com/drugs/DB21620InvestigationalAdrixetinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Adrixetinib is a tyrosine kinase inhibitor. … Adrixetinib has a monoisotopic molecular weight of 531.17 Da.
Friluglanstat
go.drugbank.com/drugs/DB21652ExperimentalFriluglanstat is a small molecule drug. The usage of the INN stem '-glanstat' in the name indicates that Friluglanstat is a prostaglandin synthase inhibitor. … Friluglanstat has a monoisotopic molecular weight of 516.12 Da.
Canlitinib
go.drugbank.com/drugs/DB21656ExperimentalCanlitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Canlitinib is a tyrosine kinase inhibitor. … Canlitinib has a monoisotopic molecular weight of 619.21 Da.
Labuxtinib
go.drugbank.com/drugs/DB21658ExperimentalLabuxtinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Labuxtinib is a tyrosine kinase inhibitor. … Labuxtinib has a monoisotopic molecular weight of 377.13 Da.
Talorasib
go.drugbank.com/drugs/DB21686ExperimentalTalorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Talorasib is a Ras protein inhibitor. Talorasib has a monoisotopic molecular weight of 604.24 Da.
PXT 3003
go.drugbank.com/drugs/DB16745InvestigationalPXT 3003 is in phase 3 clinical trials for the treatment of Charcot-Marie-Tooth disease type 1A in adults.
Olomorasib
go.drugbank.com/drugs/DB21697InvestigationalOlomorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Olomorasib is a Ras protein inhibitor. … Olomorasib is under investigation in clinical trial NCT06890598 (Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small
Enpatoran
go.drugbank.com/drugs/DB16501InvestigationalIt was investigated for systemic lupus erythematosus and cutaneous lupus erythematosus in completed trials (NCT04647708 and NCT05162586) and in a recruiting trial (NCT05540327). … Additionally, M5049 was studied for COVID-19 pneumonia in a completed trial with results (NCT04448756) and is currently being recruited for a trial involving participants with dermatomyositis and polymyositis